Asset Publisher


Spatio-temporal analysis of COVID-19 cases to inform scaling down of confinement measures as well as reactive strategies onward

A modelling analysis

Women wearing a mask and buying
Photo: Anna Shvets
04/05/2020 - 31/08/2020
Carlos Chaccour

The COVID-19 pandemic has now spread to almost all countries around the world. The response in almost all countries in Europe has been to implement a series of “non-pharmaceutical interventions” (NPIs) – including a banning of mass gatherings, closure of schools and universities, and more general restrictions on populations movements including full lockdowns. In most countries, we now have evidence to show that these NPIs have significantly reduced transmission such that the reproductive number – the average number of new infections generated by each initial infection – is close to or just below the threshold value of 1 required to bring the epidemic under control (Flaxman et al. 2020). However, there remains considerable uncertainty as to how these measures can be relaxed in the coming weeks and months whilst ensuring there are no rebound epidemics.

One of the proposed methods for relaxing existing interventions is to restrict movements to a smaller subset of the population. Two approaches are possible, alone or in tandem:

  • Restrict the movement of those at highest risk from severe disease – essentially shielding this population whilst allowing a degree of ongoing transmission in the lower risk population
  • Using app-based technology, combined with rapid testing, to rapidly isolate cases and their contacts.

The detailed data collected by the Catalonian government provide the opportunity to better understand the impact of these two approaches.

Our Team


    CARLOS CHACCOUR Assistant Research Professor. BOHEMIA Co-PI and Chief Scientific Officer

ISGlobal involved staff

    SERGI SANZ Head of Department - Statistics
  • Aina Casellas Torrentó
    Aina Casellas Torrentó

Other projects

See Past Projects


Combating Bacterial Resistance In Europe


Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting


Combatting Bacterial Resistance in Europe - Carbapenem Resistance


Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women


Integrating and decentralizing diabetes and hypertension services in Africa


Improving Care through Azithromycin Research for Infants in Africa


Predicting the Future: Incipient Tuberculosis


Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19


Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV


Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status


Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring


ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)


Digital Twins Enabled Indoor Air Quality Management for Healthy Living


Community knowledge generation through scientific culture, urban ecology and art


Building Scalable Pathogen Genomic Epidemiology in Ethiopia

Hepatitis C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.


Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias